Biological role of mannose binding lectin: From newborns to centenarians

Clinica Chimica Acta

Volumn 451, Issue , 2015, Pages 78-81

  Scorza, Manuela ^a,b   Liguori, Renato ^a,b   Elce, Ausilia ^a,c   Salvatore, Francesco ^a,b   Castaldo, Giuseppe ^a,b  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITÀ TELEMATICA PEGASO   (Italy)

Author keywords

Haplotypes; Innate immunity; MBL; Polymorphism

Indexed keywords

MANNOSE BINDING LECTIN;

ACUTE CORONARY SYNDROME; ATHEROGENESIS; AUTOIMMUNE DISEASE; BREAST CANCER; CARCINOGENESIS; CYSTIC FIBROSIS; GENETIC POLYMORPHISM; HAPLOTYPE; HEART INFARCTION; HUMAN; INFECTION; INNATE IMMUNITY; LUNG CANCER; MALIGNANT TRANSFORMATION; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENESCENCE; SEPTIC SHOCK; DEFICIENCY; GENETICS; IMMUNOLOGY; NEWBORN; VERY ELDERLY;

AGED, 80 AND OVER; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC;

EID: 84997769448     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.03.007     Document Type: Review

References (42)

1. [1] Dommett, R.M., Klein, N., Turner, M.W., Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68 (2006), 193–209.
2. [2] Jack, D.L., Klein, N.J., Turner, M.W., Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 180 (2001), 86–99.
3. [3] Matsushita, M., Endo, Y., Fujita, T., Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication. Arch Immunol Ther Exp (Warsz) 61 (2013), 273–283.
4. [4] Verdu, P., Barreiro, L.B., Patin, E., Gessain, A., Cassar, O., Kidd, J.R., et al. Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet 15 (2006), 2650–2658.
5. [5] Boldt, A.B., Messias-Reason, I.J., Meyer, D., Schrago, C.G., Lang, F., Lell, B., et al. Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genet 14 (2010), 1–12.
6. [6] Strunk, T., Currie, A., Richmond, P., Simmer, K., Burgner, D., Innate immunity in human newborn infants: prematurity means more than immaturity. J Matern Fetal Neonatal Med 24 (2011), 25–31.
7. [7] Bodamer, O.A., Mitterer, G., Maurer, W., Pollak, A., Mueller, M.W., Schmidt, W.M., Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet Med 8 (2006), 518–524.
8. [8] Auriti, C., Prencipe, G., Inglese, R., Azzari, C., Ronchetti, M.P., Tozzi, A., et al. Role of mannose binding lectin in nosocomial sepsis in critically ill neonates. Hum Immunol 71 (2010), 1084–1088.
9. [9] Schlapbach, L.J., Mattmann, M., Thiel, S., Boillat, C., Otth, M., Nelle, M., et al. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 51 (2010), 153–162.
10. [10] Nuolivirta, K., He, Q., Grondahl-Yli-Hannuksela, K., Koponen, P., Korppi, M., Helminen, M., Mannose binding lectin gene polymorphisms in infants with bronchiolitis and post-bronchiolitis wheezing. Allerg Intern 61 (2012), 305–309.
11. [11] Muñoz-Almagro, C., Bautista, C., Arias, M.T., Boixeda, R., Del Amo, E., Borrás, C., et al. High prevalence of genetically determined mannose binding lectin deficiency in young children with invasive pneumococcal disease. Clin Microbiol Infect, 2014, 10.1111/1469-0691.12615.
12. [12] Darton, T.C., Jack, D.L., Johnson, M., Borrow, R., Guiver, M., Kaczmarski, E.B., et al. MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young children. Clin Microbiol Infect, 2014, 10.1111/1469-0691.12745.
13. [13] De Pascale, G., Cutuli, S.L., Pennisi, M.A., Antonelli, M., The role of mannose binding lectin in severe sepsis and septic shock. Mediat Inflamm, 2013, 625803.
14. [14] Fidler, K.J., Wilson, P., Davies, J.C., Turner, M.W., Peters, M.J., Klein, N.J., Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 30 (2004), 1438–1445.
15. [15] Peterslund, N.A., Koch, C., Jensenius, J.C., Thiel, S., Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358 (2001), 637–638.
16. [16] Castaldo, G., Fuccio, A., Salvatore, D., Raia, V., Santostasi, T., Leonardi, S., et al. Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype. Am J Med Genet 98 (2001), 294–297.
17. [17] Salvatore, F., Scudiero, O., Castaldo, G., Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 111 (2002), 88–95.
18. [18] Chalmers, J.D., Fleming, G.B., Hill, A.T., Kilpatrick, D.C., Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: a review and meta-analysis. Glycobiology 21 (2011), 271–282.
19. [19] Tomaiuolo, R., Degiorgio, D., Coviello, D.A., Baccarelli, A., Elce, A., Raia, V., et al. An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentric study. Dig Liver Dis 41 (2009), 817–822.
20. [20] Scudiero, O., Monaco, M.L., Nigro, E., Capasso, M., Guida, M., Di Spiezio, Sardo A., Mannose-binding lectin genetic analysis: possible protective role of the HYPA haplotype in the development of recurrent urinary tract infections in men. Int J Infect Dis 19 (2014), 100–102.
21. [21] Takahashi, K., Moyo, P., Chigweshe, L., Chang, W.C., White, M.R., Hartshorn, K.L., Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study. Virus Res 178 (2013), 495–501.
22. [22] Michelow, I.C., Lear, C., Scully, C., Prugar, L.I., Longley, C.B., Yantosca, L.M., et al. High-dose mannose-binding lectin therapy for Ebola virus infection. J Infect Dis 203 (2011), 175–179.
23. [23] Ji, X., Olinger, G.G., Aris, S., Chen, Y., Gewurz, H., Spear, G.T., Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Infect Dis 203 (2011), 175–179.
24. [24] Clemons, K.V., Martinez, M., Axelsen, M., Thiel, S., Stevens, D.A., Efficacy of recombinant human mannose binding lectin alone and in combination with itraconazole against murine Candida albicans vaginitis. Immunol Invest 40 (2011), 553–568.
25. [25] Swierzko, A.S., Kilpatrick, D.C., Cedzynski, M., Mannan-binding lectin in malignancy. Mol Immunol 55 (2013), 16–21.
26. [26] Ma, Y., Uemura, K., Oka, S., Kozutsumi, Y., Kawasaki, N., Kawasaki, T., Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding protein dependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 96 (1999), 371–375.
27. [27] Hirano, M., Ma, B.Y., Kawasaki, N., Okimura, K., Baba, M., Nakagawa, T., et al. Mannan-binding protein blocks the activation of metalloproteases meprin alpha and beta. J Immunol 175 (2005), 3177–3185.
28. [28] Scudiero, O., Nardone, G., Omodei, D., Tatangelo, F., Vitale, D.F., Salvatore, F., et al. A mannose-binding lectin defective haplotype is a risk factor for gastric cancer. Clin Chem 52 (2006), 1625–1627.
29. [29] Bernig, T., Boersma, B.J., Howe, T.M., Welch, R., Yadavalli, S., Staats, B., et al. The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women. Carcinogenesis 28 (2007), 828–836.
30. [30] Pine, S.R., Mechanic, L.E., Ambs, S., Bowman, E.D., Chanock, S.J., Loffredo, C., et al. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst 99 (2007), 1401–1409.
31. [31] Pągowska-Klimek, I., Cedzyński, M., Mannan-binding lectin in cardiovascular disease. Biomed Res Int, 2014, 2014, 616817.
32. [32] Saevarsdottir, S., Oskarsson, O.O., Aspelund, T., Eiriksdottir, G., Vikingsdottir, T., Gudnason, V., et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 201 (2005), 117–125.
33. [33] Vengen, I.T., Madsen, H.O., Garred, P., Platou, C., Vatten, L., Videm, V., Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway. PLoS One, 7, 2012, e42113.
34. [34] Tomaiuolo, R., Bellia, C., Di Micco, P., Elce, A., Amato, F., Lo Sasso, B., et al. The implication of MBL deficient haplotypes in acute coronary syndrome. Exp Clin Cardiol 20 (2014), 2716–2719.
35. [35] Tomaiuolo, R., Bellia, C., Caruso, A., Di Fiore, R., Quaranta, S., Noto, D., et al. Prothrombotic gene variants as risk factors of acute myocardial infarction in young women. J Transl Med 10 (2012), 235–239.
36. [36] Mellbin, L.G., Hamsten, A., Malmberg, K., Steffensen, R., Rydén, L., Ohrvik, J., et al. Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care 33 (2010), 2451–2456.
37. [37] Verga Falzacappa, M.V., Segat, L., Puppini, B., Amoroso, A., Crovella, S., Evolution of the mannose binding lectin gene in primates. Genes Immunol 5 (2004), 653–661.
38. [38] Eisen, D.P., Osthoff, M., If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it?. Clin Exp Immunol 176 (2013), 165–171.
39. [39] Hellmann, D., Larsson, A., Madsen, H.O., Bonde, J., Jarlov, J.O., Wiis, J., et al. Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet 16 (2007), 3071–3080.
40. [40] Tomaiuolo, R., Ruocco, A., Salapete, C., Carru, C., Baggio, G., Franceschi, C., et al. Activity of mannose-binding lectin (MBL) in centenarians. Aging Cell 11 (2012), 394–400.
41. [41] Deiana, L., Ferrucci, L., Pes, G.M., Carru, C., Delitala, G., Ganau, A., et al. AKentAnnos. The Sardinia study of extreme longevity. Aging 11 (1999), 142–149.
42. [42] Blondal, J.A., Dick, J.E., Wright, J.A., Membrane glycoprotein changes during the senescence of normal human diploid fibroblasts in culture. Mech Ageing Dev 30 (1985), 273–283.